Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL-induced caspase activation
Open Access
- 30 December 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-12
Abstract
RNF183 is a ubiquitin ligase containing RING-finger and transmembrane domains, and its expression levels are increased in patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, and in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice. Here, we further demonstrate that RNF183 was induced to a greater degree in the dextran sulfate sodium (DSS)-treated IBD model at a very early stage than were inflammatory cytokines. In addition, fluorescence-activated cell sorting and polymerase chain reaction analysis revealed that RNF183 was specifically expressed in epithelial cells of DSS-treated mice, which suggested that increased levels of RNF183 do not result from the accumulation of immune cells. Furthermore, we identified death receptor 5 (DR5), a member of tumour necrosis factor (TNF)-receptor superfamily, as a substrate of RNF183. RNF183 mediated K63-linked ubiquitination and lysosomal degradation of DR5. DR5 promotes TNF-related apoptosis inducing ligand (TRAIL)-induced apoptosis signal through interaction with caspase-8. Inhibition of RNF183 expression was found to suppress TRAIL-induced activation of caspase-8 and caspase-3. Thus, RNF183 promoted not only DR5 transport to lysosomes but also TRAIL-induced caspase activation and apoptosis. Together, our results provide new insights into potential roles of RNF183 in DR5-mediated caspase activation in IBD pathogenesis.Keywords
Funding Information
- Japan Society for the Promotion of Science (19K16373, 17H06416, 17H06416)
This publication has 44 references indexed in Scilit:
- Endocytic regulation of cytokine receptor signalingCytokine & Growth Factor Reviews, 2016
- E3 Ubiquitin ligase RNF183 Is a Novel Regulator in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis, 2016
- c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistanceCellular Signalling, 2010
- Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel diseasePathology - Research and Practice, 2010
- Downregulation of epithelial apoptosis and barrier repair in active Crohn’s disease by tumour necrosis factor α antibody treatmentGut, 2004
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgeryJournal of Gastroenterology and Hepatology, 2002
- Mechanisms Underlying UbiquitinationAnnual Review of Biochemistry, 2001
- Increased sensitivity to dextran sodium sulfate colitis in IRE1β-deficient miceJournal of Clinical Investigation, 2001
- Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis.Gut, 1982